Clareo Health | A Study Evaluating the Use of ResAppDx v2.0 as an Aid to Diagnose Respiratory Disease in Paediatric Patients in an Emergency Department
Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
ResApp Health Limited
Age
0–12
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Infants and children, aged from 29 days to less than 12 years of age.
1. Presenting to the study site with current signs or symptoms of rhinorrhea, cough, wheeze, stridor, increased work of breathing, cyanosis, additional auscultatory noises (crepitations), or low oximetry levels.
2. Onset of symptoms must have occurred within the past 14 days.
You may not be if
1. Parent or legal guardian is unwilling or unable to sign the study informed consent form.
2. A child who, in the opinion of the investigator, is able to provide assent based on their age, maturity or psychological state is unwilling or unable to sign the study assent form.
3. Patient requires mechanical ventilatory support (including invasive, CPAP, or BiPAP) or high flow nasal cannula
4. Patient has a history of structural airways abnormalities, tracheobronchomalacia, or vocal cord abnormalities (e.g. laryngomalacia, tracheomalacia, or bronchomalacia)
5. Patient has a medical contraindication to voluntary cough, including the following (only enroll if coughing spontaneously)
* Severe respiratory distress
* History of pneumothorax
* Eye, chest, or abdominal surgery in past 3 months
* Hemoptysis in the past month
6. Patient is too medically unstable to participate in study per treating clinician
7. Patient has a tracheostomy present or tube placed
8. Patient is unable to provide at 5 coughs (voluntary and/or spontaneous)
